QA: Epizyme Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001571498_2018_Epizyme_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001571498, Epizyme Inc

  xvar xval
0 AssetsCurrent 285,804,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,527,000
3 remainder_Assets 1,028,000
4 LiabilitiesCurrent 24,664,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 40,118,600
9 ResearchAndDevelopmentExpense 114,821,959
10 remainder_Expenses -220,506
11 remainder_Revenues 0
12 remainder_NetIncome 11,209,164
13 remainder_ComprehensiveNetIncome -105,812
  yvar yval
0 Assets 289,359,000
1 Liabilities 24,664,000
2 Expenses 154,720,053
3 Revenues 0
4 StockholdersEquity 264,695,000
5 NetIncome -143,510,889
6 ComprehensiveNetIncome -143,563,795
7 BaseVar 240,029,014
8 EconomicCapitalRatiobeforeLimitedLiability 2.76
9 EconomicCapitalRatio 3.53

Edgar->Model Mapping

Feature Distribution

Change over Time